CN Patent

CN113454086B — 作为tlr7激动剂的咪唑并[2,1-f][1,2,4]三嗪-4-胺衍生物

Assigned to Beone Pharmaceutical Suzhou Co Ltd · Expires 2025-03-14 · 1y expired

What this patent protects

本文披露了可用作TLR7激动剂的咪唑并[2,1‑f][1,2,4]三嗪‑4‑胺衍生物或其立体异构体、或其药学上可接受的盐，以及包含所述咪唑并[2,1‑f][1,2,4]三嗪‑4‑胺衍生物或其立体异构体、或其药学上可接受的盐的药物组合物。本文还披露了使用所述咪唑并[2,1‑f][1,2,4]三嗪‑4‑胺衍生物或其立体异构体、或其药学上可接受的盐作为TLR7激动剂治疗癌症的方法。

USPTO Abstract

本文披露了可用作TLR7激动剂的咪唑并[2,1‑f][1,2,4]三嗪‑4‑胺衍生物或其立体异构体、或其药学上可接受的盐，以及包含所述咪唑并[2,1‑f][1,2,4]三嗪‑4‑胺衍生物或其立体异构体、或其药学上可接受的盐的药物组合物。本文还披露了使用所述咪唑并[2,1‑f][1,2,4]三嗪‑4‑胺衍生物或其立体异构体、或其药学上可接受的盐作为TLR7激动剂治疗癌症的方法。

Drugs covered by this patent

Patent Metadata

Patent number: CN113454086B
Jurisdiction: CN
Classification: —
Expires: 2025-03-14
Drug substance claim: No
Drug product claim: No
Assignee: Beone Pharmaceutical Suzhou Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.